FOR IMMEDIATE RELEASE
Chair of Cure JM Foundation Medical Advisory Board Lisa Rider, MD, Wins Prestigious Research and Hope Award for Excellence in Government Research
Dr. Rider Recognized for Leadership in Juvenile Myositis Research
ENCINITAS, CA (October 17, 2016) – Lisa Rider, M.D., Chair of the Cure JM Medical Advisory Board and Deputy Unit Chief of the NIEHS Environmental Autoimmunity Group, recently received the 2016 Research and Hope Award for Excellence in Government Research from the Pharmaceutical Research and Manufacturers of America (PhRMA). Representing biopharmaceutical research companies in the United States, PhRMA selected Rider for her work with Juvenile Myositis (JM), including her development of new response criteria used to determine clinical improvement in treatment trials for juvenile and adult myositis, as well as her work to define subgroups of patients based on myositis autoantibodies, and their associated clinical features and outcomes.
Upon being selected for the award, Dr. Rider sent the following message to Cure JM Foundation:
"Thank you to all of you at Cure JM -- for all of your support and all that you do, and all of the kind words today! The accomplishments of recent years truly would not have been possible without YOUR support- really! I am also so inspired by all of the JM patients I meet, many of whom are connected to Cure JM, and by all of your efforts -- that inspiration and hope keeps me continuing to work diligently to make progress in many areas.”
Interested parties can learn more about the award on the NIH website at: www.niehs.nih.gov/
About Cure JM
Cure JM is a 501(c)(3) nonprofit organization dedicated to finding a cure for Juvenile Dermatomyositis (JDM) and Juvenile Polymyositis (JPM), the rare and life-threatening autoimmune diseases collectively known as Juvenile Myositis (JM). Approximately 2 to 4 children in a million in the United States are diagnosed with JM each year.
Cure JM’s mission is to provide support for families coping with JM, raise awareness of JM, and fund research that will ultimately lead to a cure.
Cure JM Foundation is the only organization that solely supports Juvenile Myositis and is also the largest charitable supporter of Juvenile Myositis research. Through the generosity of the JM community, family and friends, Cure JM has helped establish JM research centers in Chicago and Washington, D.C., and funded the first-ever book solely about JM. Cure JM has also funded a wide range of genetic and JM treatment studies and funded research fellowships. For more information on Cure JM visit www.curejm.org